Massoud Toussi

Vice President, Global Head of Real-World Evidence

Massoud has over 20 years of experience in the design, development, and conduct of studies in ​​real-world evidence, pharmacoepidemiology, ​​Post-Authorization Safety Studies (PASS), outcomes research, and data science.

Prior to joining Cytel in 2023, Massoud established the pharmacoepidemiology and pharmacovigilance services in three companies. He has contributed to several publications and guidelines of PASS, and is a co-author of the PASS Book, a reference in this area known around the world.

Massoud has a PhD from l’Université Paris 13, and an MBA from Université Paris Dauphine and Université du Québec à Montréal.